Total planned funding: $44,756,402
Allocations
Countries/Regions
| Central Asia Region | $44,756,402 |
Organizational Types
| Own Agency | $14,588,651 |
| Unknown | $8,434,862 |
| NGO | $5,720,994 |
| University | $5,376,750 |
| Host Country Government Agency | $5,166,016 |
| Private Contractor | $4,282,129 |
| Multi-lateral Agency | $1,020,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $0 |
Program Areas
| Prevention | $15,423,736 |
| Management and Operations | $10,811,348 |
| Governance and Systems | $7,775,968 |
| Care | $5,743,393 |
| Testing | $2,555,693 |
| Treatment | $2,446,264 |
Budget Codes
| HVMS: Management and Operations | $10,811,348 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,539,712 |
| HBHC: Care: Adult Care and Support | $4,863,617 |
| HLAB: Laboratory Infrastructure | $3,748,755 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,639,537 |
| HVCT: Testing: HIV Testing and Counseling | $2,555,693 |
| HTXS: Treatment: Adult Treatment | $2,420,244 |
| HVSI: Strategic Information | $2,395,379 |
| OHSS: Health Systems Strengthening | $1,631,834 |
| HMBL: Biomedical Prevention: Blood Safety | $916,738 |
| HVTB: Care: TB/HIV | $879,776 |
| HMIN: Biomedical Prevention: Injection Safety | $327,749 |
| HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
USG Aggregated Agencies:
$9,226,288
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2016 | $4,126,289 |
Not Available:
$8,434,862
Countries/Regions
Central Asia Region
| 2011 | $1,092,788 |
| 2014 | $7,315,722 |
| 2016 | $26,352 |
Columbia University:
$5,376,750
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2014 | $1,051,915 |
| 2016 | $3,397,092 |
Population Services International:
$3,310,994
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2014 | $0 |
| 2016 | $0 |